Opko Health to present data on HGH at ENDO 2016

30 Mar 2016


Opko Health Inc has announced it will present 18-24 month clinical data from its ongoing open-label extension study for its long-acting human growth hormone (hGH-CTP) in an oral presentation at the Endocrine Society’s 98th Annual Meeting in Boston. 

Sonoran Weekly


Share this story